Deng GF - Search Results

1

Patient pathway analysis of tuberculosis diagnostic delay: a multicentre retrospective cohort study in China.

Zhang L, Weng TP, Wang HY, Sun F, Liu YY, Lin K, Zhou Z, Chen YY, Li YG, Chen JW, Han LJ, Liu HM, Huang FL, Cai C, Yu HY, Tang W, Huang ZH, Wang LZ, Bao L, Ren PF, Deng GF, Lv JN, Pu YL, Xia F, Li T, Deng Q, He GQ, Li Y, Zhang WH. Zhang L, et al. Among authors: deng gf, deng q. Clin Microbiol Infect. 2021 Jul;27(7):1000-1006. doi: 10.1016/j.cmi.2020.12.031. Epub 2021 Jan 6. Clin Microbiol Infect. 2021. PMID: 33421578 Free article.

2

Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.

Yuan X, Zhang T, Kawakami K, Zhu J, Zheng W, Li H, Deng G, Tu S, Liu W. Yuan X, et al. BMC Infect Dis. 2013 Jul 12;13:315. doi: 10.1186/1471-2334-13-315. BMC Infect Dis. 2013. PMID: 23849244 Free PMC article.

3

Indicators for prediction of Mycobacterium tuberculosis positivity detected with bronchoalveolar lavage fluid.

Liu X, Hou XF, Gao L, Deng GF, Zhang MX, Deng QY, Ye TS, Yang QT, Zhou BP, Wen ZH, Liu HY, Kornfeld H, Chen XC. Liu X, et al. Among authors: deng gf, deng qy. Infect Dis Poverty. 2018 Mar 24;7(1):22. doi: 10.1186/s40249-018-0403-x. Infect Dis Poverty. 2018. PMID: 29580276 Free PMC article.

4

Empirical treatment with non-anti-tuberculosis antibiotics decreased microbiological detection in cervical tuberculous lymphadenitis.

Dai Y, Wen Z, Ye T, Deng G, Zhang M, Deng Q, Yang Q, Shan W, Kornfeld H, Cai Y, Chen X. Dai Y, et al. Diagn Microbiol Infect Dis. 2018 Nov;92(3):245-249. doi: 10.1016/j.diagmicrobio.2018.06.008. Epub 2018 Jun 20. Diagn Microbiol Infect Dis. 2018. PMID: 30076042

5

Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis.

Fu L, Weng T, Sun F, Zhang P, Li H, Li Y, Yang Q, Cai Y, Zhang X, Liang H, Chen X, Wang Z, Liu L, Zhang W, Deng G. Fu L, et al. Int J Infect Dis. 2021 Oct;111:138-147. doi: 10.1016/j.ijid.2021.08.055. Epub 2021 Aug 25. Int J Infect Dis. 2021. PMID: 34454119 Free article. Clinical Trial.

6

Adjunctive interleukin-2 for the treatment of drug-susceptible tuberculosis: a randomized control trial in China.

Nie W, Wang J, Zeng J, Wang Q, Du Y, Tan Q, Xie W, Deng Q, Deng G, Li X, Li Z, Zhao J, Pang J, Luan K, Chu L, Duan H, Zhang C, Ji Q, Chen X, Chen J, Wang N, Chen Y, Qiu C, Deng A, Ren P, Liu Y, Li C, Cao S, Liu H, Yan H, Chu N. Nie W, et al. Infection. 2022 Apr;50(2):413-421. doi: 10.1007/s15010-021-01698-3. Epub 2021 Sep 25. Infection. 2022. PMID: 34562262 Clinical Trial.

7

Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China.

Fang MT, Su YF, An HR, Zhang PZ, Deng GF, Liu HM, Mao Z, Zeng JF, Li G, Yang QT, Wang ZY. Fang MT, et al. Among authors: deng gf. BMC Infect Dis. 2021 Sep 28;21(1):1015. doi: 10.1186/s12879-021-06705-4. BMC Infect Dis. 2021. PMID: 34583653 Free PMC article.

8

Diagnostic Performance of a Novel CXCL10 mRNA Release Assay for Mycobacterium tuberculosis Infection.

Pan L, Huang M, Jia H, Deng G, Chen Y, Wei R, Zhang M, Li X, Sun Q, Fang M, Ren P, Xing A, Chen Q, Li X, Du B, Chen T, Gao M, Zhang Z. Pan L, et al. Front Microbiol. 2022 Mar 30;13:825413. doi: 10.3389/fmicb.2022.825413. eCollection 2022. Front Microbiol. 2022. PMID: 35432271 Free PMC article.

9

Selecting an appropriate all-oral short-course regimen for patients with multidrug-resistant or pre-extensive drug-resistant tuberculosis in China: A multicenter prospective cohort study.

Fu L, Zhang X, Xiong J, Sun F, Weng T, Li Y, Zhang P, Li H, Yang Q, Cai Y, Liang H, Chen Q, Wang Z, Liu L, Chen X, Zhang W, Deng G. Fu L, et al. Int J Infect Dis. 2023 Oct;135:101-108. doi: 10.1016/j.ijid.2023.08.001. Epub 2023 Aug 10. Int J Infect Dis. 2023. PMID: 37567554 Free article.

10

Study protocol for safety and efficacy of all-oral shortened regimens for multidrug-resistant tuberculosis: a multicenter randomized withdrawal trial and a single-arm trial [SEAL-MDR].

Fu L, Xiong J, Wang H, Zhang P, Yang Q, Cai Y, Wang W, Sun F, Zhang X, Wang Z, Chen X, Zhang W, Deng G. Fu L, et al. BMC Infect Dis. 2023 Nov 27;23(1):834. doi: 10.1186/s12879-023-08644-8. BMC Infect Dis. 2023. PMID: 38012543 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters